Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
16,857,707
-
Share change
-
+1,376,948
-
Total reported value
-
$185,279,386
-
Price per share
-
$10.99
-
Number of holders
-
68
-
Value change
-
+$14,954,366
-
Number of buys
-
37
-
Number of sells
-
18
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q4 2016
As of 31 Dec 2016,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,857,707 shares.
The largest 10 holders included
FMR LLC, PUTNAM INVESTMENTS LLC, DEERFIELD MANAGEMENT CO, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Tekla Capital Management LLC, Redmile Group, LLC, BlackRock Fund Advisors, VHCP Management II, LLC, and BVF INC/IL.
This page lists
68
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.